Education
About Us
Working with TipRanks
Follow Us
Apiam Animal Health Ltd. (AU:AHX)
ASX:AHX
AHX Stock Chart & Stats
AU$0.88
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.88
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.35 - AU$0.88
Previous CloseN/A
Volume2.56K
Average Volume (3M)293.45K
Market Cap
AU$164.41M
Enterprise ValueAU$264.43M
Total Cash (Recent Filing)AU$2.52M
Total Debt (Recent Filing)AU$102.54M
Price to Earnings (P/E)190.2
Beta0.12
Next Earnings
Aug 31, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.3%
Share Statistics
EPS (TTM)N/A
Shares Outstanding187,899,890
10 Day Avg. Volume597,364
30 Day Avg. Volume293,452
Financial Highlights & Ratios
PEG Ratio-1.36
Price to Book (P/B)0.78
Price to Sales (P/S)0.46
P/FCF Ratio8.72
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue GrowthSustained revenue growth of ~22.9% indicates expanding clinic volumes and service adoption across companion and production segments. This durable top-line momentum supports scaling of network economics, recurring farm relationships and reinvestment in services or acquisitions over the next 2–6 months.
High Gross MarginA 66.2% gross margin reflects pricing power and high-value clinical services mix. This structural margin buffer helps absorb input cost pressures and funds reinvestment in diagnostics and clinic upgrades, underpinning sustainable operating leverage if SG&A is managed over upcoming quarters.
Manageable LeverageA moderate debt-to-equity (~0.85) with a healthy equity ratio indicates capacity to finance organic expansion or targeted acquisitions without overburdening cash flow. This balance-sheet posture supports strategic flexibility and resilience to sector cyclicality over a multi-month horizon.
Bears Say
Compressed Net MarginA decline to 0.4% net margin shows the company struggles to translate strong gross margins into bottom-line profits. Persistent compression limits retained earnings and strategic reinvestment, increasing reliance on operational improvements to restore sustainable profitability over the medium term.
Weak Cash GenerationNegative free cash flow growth and falling operating cash flow reduce internal funding for capex, acquisitions and dividends. This structural cash-generation weakness may necessitate external financing or tighter working-capital controls, constraining strategic options and resilience over coming quarters.
Low Return On EquityA 0.7% ROE indicates poor capital efficiency and difficulty converting equity into shareholder returns. Persistently low ROE can limit investor confidence and the company's ability to attract capital for growth initiatives, posing a structural challenge to long-term value creation.
Apiam Animal Health Ltd. News
AHX FAQ
What was Apiam Animal Health Ltd.’s price range in the past 12 months?
Apiam Animal Health Ltd. lowest share price was AU$0.34 and its highest was AU$0.88 in the past 12 months.
What is Apiam Animal Health Ltd.’s market cap?
Apiam Animal Health Ltd.’s market cap is AU$164.41M.
When is Apiam Animal Health Ltd.’s upcoming earnings report date?
Apiam Animal Health Ltd.’s upcoming earnings report date is Aug 31, 2026 which is in 191 days.
How were Apiam Animal Health Ltd.’s earnings last quarter?
Currently, no data Available
Is Apiam Animal Health Ltd. overvalued?
According to Wall Street analysts Apiam Animal Health Ltd.’s price is currently Overvalued.
Does Apiam Animal Health Ltd. pay dividends?
Apiam Animal Health Ltd. pays a Semiannually dividend of AU$0.01 which represents an annual dividend yield of 2.3%. See more information on Apiam Animal Health Ltd. dividends here
What is Apiam Animal Health Ltd.’s EPS estimate?
Apiam Animal Health Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Apiam Animal Health Ltd. have?
Apiam Animal Health Ltd. has 187,899,890 shares outstanding.
What happened to Apiam Animal Health Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Apiam Animal Health Ltd.?
Currently, no hedge funds are holding shares in AU:AHX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Apiam Animal Health Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
68.04%
12-Months-Change
Fundamentals
Return on Equity
0.68%
Trailing 12-Months
Asset Growth
<0.01%
Trailing 12-Months
Company Description
Apiam Animal Health Ltd.
Apiam Animal Health Limited, a vertically integrated animal health company, provides veterinary products and services to production and companion animals in Australia. The company operates through three segments: Dairy and Mixed, Feedlots, and Pigs. It engages in the provision of veterinary wholesale, diagnostics laboratories, custom vaccines, logistics, and other ancillary services. The company offers companion animal, dairy, swine and poultry, beef feedlot, equine, sheep, and genetic services. It also provides telemedicine, remote video headgear, health management apps for production animals systems, benchmarking databases, and herd management software. The company offers general animal health products through eCommerce. It provides its services through animal veterinary clinics. The company was founded in 1998 and is based in Bendigo, Australia.
Technical Analysis
AF Legal Group Limited
―
Propel Funeral Partners Ltd.
―
Shine Justice Ltd.
―
Experience Co Ltd
―
Mayfield Childcare Ltd.
―
Options Prices
Currently, No data available
---